Skip to content

Health / Manulife Syariah

Manulife Miultimate Healthcare Syariah

Syariah Health agency Full brief · 2026-06-17

MiUltimate Healthcare Syariah is Manulife's flagship Syariah comprehensive medical card — a yearly-renewable, cashless, "as-charged" (sesuai tagihan) hospital plan built on a takaful (tolong-menolong / mutual-help) structure.

★ The Insurer’s Play

analytical interpretation

Why this product exists

To capture recurring health-protection premiums in a fast-growing private-medical market — specifically, to sell a private "speed layer" sitting above public BPJS cover and comply with the POJK 36/2025 co-payment redesign for health cover.

What the insurer wants the agent to do

Steer the agent to position it as a fast private top-up to BPJS, not a replacement, explain the specific co-payment mechanism clearly, and qualify for higher-income, larger-sum cases.

Inferred from: BPJS positioningPOJK 36/2025 co-paymentaffluent / legacy segmentSyariah / pilgrimage structuresavings / return-of-premium benefitcompetitive positioning (§4)

Our read of the insurer’s design intent — not their stated words. Use it to judge fit, not as a fact about the policy.

Who this fits — and who it doesn’t

✓ Fits when…

  • Age 30–50, married, with children, mass-affluent and above
  • Sharia-observant or Sharia-preferring — wants "halal," "sesuai prinsip Islam," no riba
  • Household income comfortably able to carry a rising yearly-renewable medical contribution
  • Already values comprehensive cover: as-charged surgery, ICU, cancer and dialysis benefits
  • Wants regional or worldwide cover (travels, or seeks treatment in Malaysia / Singapore)
  • Values long-horizon renewability — thinking about cover into old age, not just this decade

~ Borderline — qualify carefully

  • Cost-sensitive Sharia prospect who likes the brand but balks at top-tier contribution — the Sapphire / Jade entry tiers exist precisely for this, and so does Allianz AlliSya. This is the contested middle.
  • Prospect who is indifferent on Sharia but attracted by the Rp20B headline — vulnerable to a conventional-vs-Syariah cost comparison.
  • Existing BPJS member wanting a private "top-up" — needs careful needs-analysis; may be over-sold a Diamond plan when a mid-tier suffices.

✕ Not a fit when…

  • Customers who primarily need life/legacy cover, not hospital cover — wrong category
  • Pure price-floor buyers with no medical cover at all and tight budgets — BPJS plus a modest plan is the honest answer
  • Customers with significant pre-existing conditions — the 12-month and 2-year exclusions and full underwriting will frustrate them; manage expectations early
  • Customers who will not commit to ongoing yearly-renewable contributions — a YRT medical card that rises with age punishes lapsers

The trade-offs — when it wins, when it doesn’t

No product wins for everyone. Here’s when Manulife Miultimate Healthcare Syariah is the right call — and when a different product is.

SHARIA-MINDED, WANTS A LEGACY INCOME CARRIER

Lead:Allianz Syariah AlliSya health

It is the carrier you can actually write. Match the Sharia structure; pitch Allianz's surplus-sharing and network on equal Sharia footing.

VALUES SURPLUS SHARING WITH THE PARTICIPANT

Lead:a peer that distributes Surplus Underwriting to participants

Manulife returns surplus to the Tabarru' fund, not to the individual participant — several Syariah peers share surplus back. A real talking point.

PRICE IS THE DECIDING FACTOR, SHARIA NOT ESSENTIAL

Lead:conventional medical

Syariah contribution is not automatically cheaper; Ujrah loads year 1 are high (77–81% of contribution). A like-for-like conventional plan may quote lower.

WANTS LOWEST OUT-OF-POCKET AT CLAIM TIME

This product applies a 20% co-pay outside Manulife Preferred Hospitals (capped Rp50M–Rp100M/yr). In-network is the only way to avoid it. Compare against the peer's co-pay design.

BUDGET MINIMAL, BASIC COVER ONLY NEEDED

Lead:BPJS Kesehatan + small top-up / self-insurance

A Rp20B Diamond plan is wildly over-specced for a modest household. Honest needs-analysis wins trust.

HEAVY PRE-EXISTING HISTORY

Lead:managed expectations; possibly defer

12-month and 2-year waiting lists plus full underwriting make this a poor near-term fit regardless of carrier.

⚠ Compliance red flags & mis-selling warnings

These apply both to understanding the Manulife product and to writing Allianz AlliSya cleanly. Build Legacy Income training around all of them.

  1. POJK 36/2025 co-payment regime (effective January 2026). Every health product must now apply a co-payment structure. MiUltimate Healthcare Syariah applies 20% co-pay on treatment outside Manulife Preferred Hospitals (capped Rp50M/yr for Topaz–Sapphire tiers, Rp100M/yr for Diamond–Emerald tiers); 0% co-pay in-network. Any agent — Manulife or Legacy Income — who quotes “fully cashless, no out-of-pocket” without disclosing the out-of-network co-pay is mis-selling under the new regime. Always disclose the co-pay and confirm the customer’s hospital is in-network.

  2. Tabarru’ fund deficit risk. The Dana Tabarru’ is a mutual-help fund; in a takaful structure, sustained adverse claims can pressure the fund. Surplus here is returned to the fund (not the participant), which supports resilience, but the customer should understand that benefits are paid from a collective fund, not an individual account. Do not represent contributions as a personal savings balance.

  3. Wakalah bil Ujrah fee transparency. The Ujrah (manager fee) is high in year one (~77–81% of contribution per the allocation table). This is disclosed in the RIPLAY but easily glossed over verbally. Walk the customer through the year-1 vs year-2+ Ujrah split honestly — failing to disclose the front-loaded fee is a classic Syariah mis-selling complaint.

  4. Akad clarity at SPAJ stage. Syariah products require the customer to understand and agree to the specific Akad (Tabarru’, Wakalah bil Ujrah). The application (Surat Permintaan / Formulir Pendaftaran Syariah) must reflect genuine informed consent to the Akad — not a rushed signature. Confirm the customer can state, in their own words, that their contribution is a donation to a mutual fund managed by the company for a fee.

  5. 12-month pre-existing / specified-illness exclusion. A long list of conditions (all tumours/cancers, cardiovascular disease and stroke, diabetes, hypertension, hernia, kidney/bladder stones, thyroid disease and more) is excluded if it arises within 12 months of policy issuance; cataract has a 2-year wait; cancer diagnosed within 90 days of issuance is excluded; 30-day general elimination period; 12-month HIV/AIDS elimination. Cashless is unavailable for chronic and 18 specified illnesses for the first 2 years (reimbursement still applies). A clean SPAJ that hides a known condition creates a future repudiation — and a complaint. Underwrite honestly.

  6. Yearly-renewable contribution escalation. This is a Yearly Renewable Term medical card: contributions rise with age at each renewal. Selling it on a low year-1 contribution without warning the customer that it will climb materially over the years is mis-selling. Show a multi-year contribution trajectory, not just the entry figure.

  7. Geographic / plan-tier mismatch. The plan tiers carry very different geographic scopes (worldwide ex-USA at Diamond down to Indonesia-only at Jade/Sapphire) and very different room rates. Selling a low tier to a customer who expects worldwide cover, or a Diamond to a customer who never travels and cannot afford the contribution, are both mis-sells. Match the tier to the actual need and budget.


Internal training guidance. Always confirm against the current RIPLAY/policy — the policy is the binding document.

Expert · technical detail

Raw fields

Entity type
syariah
Channel
agency
Category
health
Benchmark carrier
no
Extraction quality
pdf-downloaded
First cataloged
2026-04-25
Last updated
2026-04-29
Brief date
2026-06-17
Analyst confidence
Medium-High — structural and Sharia-mechanic claims are read directly from the RIPLAY tables; competitor comparisons are analyst judgment from category knowledge, not parsed against peer RIPLAYs.

Source documents

No source document URLs on record.

On-disk (read-only upstream):
documents/manulife-syariah/syariah/manulife-miultimate-healthcare-syariah/riplay-2026-04-29.pdf
documents/manulife-syariah/syariah/manulife-miultimate-healthcare-syariah/brochure-2026-04-29-v1.pdf

Insurer product page ↗

How Health products differ

Fully benchmarked · 93% coverage

No product wins every dimension — these are trade-offs, not a scoreboard. Where the dataset can’t yet support hard medians, we show the observed range and the analyst’s read.

Annual benefit limit qualitative
Rp 250M (entry tier — multiple insurers) Rp 20B (top-tier with auto-increase — Sun Healthcare Safir Plus)

Direct comparison limited by plan-tiering heterogeneity

Renewable to age qualitative

Observed: 80 · 99 · 100

Allianz AlliSya caps at age 80; Sun Healthcare Solution Syariah and Prudential PRUwell Medical Syariah both reach ~age 99-100; longest tail wins for younger entrants

Co-payment (POJK 36/2025) qualitative

POJK 36/2025 effective January 2026 — every health product across the category must apply a co-payment structure. Per-episode vs per-claim vs aggregate annual deductible structures vary; agents must explain the specific mechanism for the product being sold.

Underwriting qualitative
Geographic coverage qualitative

Most insurers offer Indonesia-only at entry tier; ASEAN regional coverage (Malaysia/Singapore) at mid-tier; global coverage at top-tier with reduced reimbursement percentage. Allianz AlliSya Flexi reportedly extends to US coverage at top tier.

Tabarru'/Ujrah split (Syariah) qualitative

Sun Healthcare Solution Syariah: 37-45% Ujrah depending on plan (high end on Opal/Safir). AIA Syariah typically 35-40%. Allianz Syariah varies.

Coverage caveat: Per-product detail extraction is at ~50% coverage across the 36 active health products. Cross-product comparisons in Section 5 of any health brief produced this run rely on qualitative observations and structured peer-product references (Allianz AlliSya line, Prudential PRU lines, and the four Sun Life Syariah briefs already produced — healthcare-solution-syariah, shifa-essential, shifa-signature, salam-anugerah-harapan). (sample: ~30 products)

Expert · full Strategic Brief

1. The 60-Second Pitch

MiUltimate Healthcare Syariah is Manulife’s flagship Syariah comprehensive medical card — a yearly-renewable, cashless, “as-charged” (sesuai tagihan) hospital plan built on a takaful (tolong-menolong / mutual-help) structure. It is the Syariah twin of Manulife’s conventional MiUltimate Healthcare line, and it competes at the top end of the Indonesian health market.

What makes it formidable from a competitive standpoint:

  1. Category-ceiling annual limit. The top plan (Diamond) carries an annual limit of Rp20 billion — at the very top of the Indonesian health category — plus a Limit Booster of up to Rp15 billion for all illnesses once the annual limit is exhausted.
  2. Renewal to age 110. Coverage is renewable yearly up to insured age 110 — the longest renewal ceiling currently observed in the category (peers cluster at 80, 99, or 100).
  3. Eight plan tiers from Diamond down to Sapphire, with geographic coverage scaling from worldwide-except-USA down to Indonesia-only — a wide ladder that lets the Manulife agent meet almost any budget.
  4. A genuine Syariah wrapper: Akad Tabarru’ (mutual donation) plus Akad Wakalah bil Ujrah (the manager acts as the participants’ agent for a fee), OJK-approved and certified by the Dewan Pengawas Syariah under Fatwa DSN-MUI No. 21/DSN-MUI/X/2001.

In one line for the Legacy Income agent: this is the product an affluent, Sharia-minded prospect will most likely be shown by a Manulife agent — and the case against it is built on price discipline, surplus-sharing transparency, and the strength of Allianz’s own Syariah offer, not on dismissing it.


2. Headline Numbers Decoded

There is no published sample illustration with contribution (premium) figures in the RIPLAY — the only illustration shows benefit payouts for a 40-year-old on the Jade Smart plan, not the contribution he pays. The agent must produce a quote in the field. What the documents do publish are the benefit ceilings, which are the real headline numbers in a medical card. Decoded by plan tier (annual limits in IDR):

Critical insight for the Legacy Income agent: the Rp20B headline is real and impressive, but almost no Indonesian customer ever spends near it. The genuine selling points a Manulife agent will lean on are the room rate, the as-charged surgical/ICU cover, and the age-110 renewal — not the top-line limit. Anchor your counter-pitch on the dimensions that actually bite in a claim: co-payment exposure, contribution escalation at renewal, and whether the customer’s preferred hospital is in-network.


ANNUAL LIMIT — DIAMOND (TOP TIER)

Rp 20.0 billion

Plus Limit Booster up to

Rp 15.0B for all illnesses.

Sits at the category ceiling.

ANNUAL LIMIT — RUBY

Rp 15.0 billion

Plus booster up to Rp 10.0B.

ANNUAL LIMIT — EMERALD / TOPAZ /

TOPAZ INDONESIA

Rp 10.0 billion each

Plus booster up to Rp 8.0B.

ANNUAL LIMIT — JADE /

JADE INDONESIA

Rp 4.0 billion each

Plus booster up to Rp 6.0B.

ANNUAL LIMIT — SAPPHIRE

(ENTRY TIER)

Rp 2.0 billion

Plus booster up to Rp 1.0B.

ROOM RATE — DIAMOND

Rp 3.0M / day or single

standard room, whichever higher.

Worldwide except USA.

ROOM RATE — JADE / SAPPHIRE

Rp 500K / day or double

standard room, whichever higher.

Indonesia / regional only.

GEOGRAPHIC LADDER

Diamond:Worldwide ex-USA

Ruby:Worldwide ex-USA

Emerald:Asia ex-SG/HK/JP

Topaz:Asia ex-SG/HK/JP

Jade:Indonesia

Sapphire:Indonesia

Read:cover shrinks as you step down the ladder.

NO CLAIM BONUS

+10% of annual limit per

claim-free year, max +50%

cumulative.

NO CLAIM DISCOUNT

10% contribution discount after

1 claim-free year; 15% after 2+.

FAMILY DISCOUNT

5% when family members are

added to the plan.

3. Ideal Customer Profile

This section describes who this product fits, so the Legacy Income agent can recognise — and where appropriate, redirect — the prospect.

Sweet Spot — the prospect Manulife will win unless you contest it

  • Age 30–50, married, with children, mass-affluent and above
  • Sharia-observant or Sharia-preferring — wants “halal,” “sesuai prinsip Islam,” no riba
  • Household income comfortably able to carry a rising yearly-renewable medical contribution
  • Already values comprehensive cover: as-charged surgery, ICU, cancer and dialysis benefits
  • Wants regional or worldwide cover (travels, or seeks treatment in Malaysia / Singapore)
  • Values long-horizon renewability — thinking about cover into old age, not just this decade

Borderline Fit — winnable either way

  • Cost-sensitive Sharia prospect who likes the brand but balks at top-tier contribution — the Sapphire / Jade entry tiers exist precisely for this, and so does Allianz AlliSya. This is the contested middle.
  • Prospect who is indifferent on Sharia but attracted by the Rp20B headline — vulnerable to a conventional-vs-Syariah cost comparison.
  • Existing BPJS member wanting a private “top-up” — needs careful needs-analysis; may be over-sold a Diamond plan when a mid-tier suffices.

Do Not Pitch (this product is the wrong tool)

  • Customers who primarily need life/legacy cover, not hospital cover — wrong category
  • Pure price-floor buyers with no medical cover at all and tight budgets — BPJS plus a modest plan is the honest answer
  • Customers with significant pre-existing conditions — the 12-month and 2-year exclusions and full underwriting will frustrate them; manage expectations early
  • Customers who will not commit to ongoing yearly-renewable contributions — a YRT medical card that rises with age punishes lapsers

4. Decision Framework — When the Alternative Beats MiUltimate Healthcare Syariah

This is the Legacy Income angle: when does Allianz Syariah AlliSya, a conventional plan, or self-insurance beat Manulife’s product?

Rule of thumb: if the prospect’s first words include “syariah,” “halal,” “riba,” or “sesuai prinsip Islam,” you are in a Sharia conversation — and Legacy Income has a Sharia answer in Allianz AlliSya, so do not concede the category. Compete on carrier strength, surplus-sharing transparency, and network — not by attacking the concept. If the prospect leads with “yang penting murah” (the main thing is cheap) or “limit paling tinggi” (highest limit), the conversation is about price and headline numbers, where a conventional or mid-tier plan often wins.


SHARIA-MINDED, WANTS A LEGACY INCOME CARRIER

Lead:Allianz Syariah AlliSya health

It is the carrier you can actually write. Match the Sharia structure; pitch Allianz's surplus-sharing and network on equal Sharia footing.

VALUES SURPLUS SHARING WITH THE PARTICIPANT

Lead:a peer that distributes Surplus Underwriting to participants

Manulife returns surplus to the Tabarru' fund, not to the individual participant — several Syariah peers share surplus back. A real talking point.

PRICE IS THE DECIDING FACTOR, SHARIA NOT ESSENTIAL

Lead:conventional medical

Syariah contribution is not automatically cheaper; Ujrah loads year 1 are high (77–81% of contribution). A like-for-like conventional plan may quote lower.

WANTS LOWEST OUT-OF-POCKET AT CLAIM TIME

This product applies a 20% co-pay outside Manulife Preferred Hospitals (capped Rp50M–Rp100M/yr). In-network is the only way to avoid it. Compare against the peer's co-pay design.

BUDGET MINIMAL, BASIC COVER ONLY NEEDED

Lead:BPJS Kesehatan + small top-up / self-insurance

A Rp20B Diamond plan is wildly over-specced for a modest household. Honest needs-analysis wins trust.

HEAVY PRE-EXISTING HISTORY

Lead:managed expectations; possibly defer

12-month and 2-year waiting lists plus full underwriting make this a poor near-term fit regardless of carrier.

5. Product Benchmarking vs the Health Category

The Indonesian health category is structurally heterogeneous (per-tier room rates, as-charged vs inner-limit designs, varying geographic scopes), so quantitative population benchmarking is not available — there is no defensible numeric median. The comparison below is descriptive and qualitative, against observed category ranges. Conventional and Syariah products are treated as one unified market (customers move freely), with a dedicated Sharia sub-block.

Confidence note: structural and Sharia-mechanic claims are high-confidence — read directly from the RIPLAY contribution-allocation, benefit, and Akad tables. Category-range figures (annual-limit floor/ceiling, peer renewal ceilings, peer Ujrah ranges) are analyst context, not parsed from peer RIPLAYs this cycle. Quantitative benchmarking is not available for the health category. Refresh trigger: re-run when health-category PDF coverage and Syariah peer RIPLAY parsing allow numeric medians.


STRUCTURAL DIMENSIONS

ANNUAL LIMIT (TOP TIER)

Category range:~Rp250M floor; ~Rp20B ceiling; mid ~Rp2-3B

This product:Rp20B (Diamond)

Read:At the category ceiling. A genuine top-decile strength.

PLAN LADDER BREADTH

Category typical:3-5 tiers

This product:8 tiers (Diamond → Sapphire)

Read:Unusually broad; covers a wide budget spectrum.

RENEWAL CEILING AGE

Category observed:80 (Allianz AlliSya), 99-100 (Sun, Pru)

This product:110

Read:Longest observed ceiling in category. Strong for the long-horizon buyer.

BENEFIT BASIS

Category typical:Mix of as-charged and inner-limit

This product:Largely as-charged (sesuai tagihan) on core hospital items

Read:Competitive; in line with premium-tier peers.

GEOGRAPHIC SCOPE

Category typical:Indonesia to regional; few worldwide

This product:Worldwide ex-USA at top; Indonesia at entry — scales by tier

Read:Flexible; top tiers are genuinely international.

LIMIT BOOSTER

Category typical:Some peers offer a top-up after limit

This product:Up to Rp15B booster (Diamond), all illnesses

Read:Strong; not unique but generous at the top tier.

ECONOMIC DIMENSIONS

CO-PAYMENT DESIGN

Category context:POJK 36/2025 mandates co-pay from Jan 2026

This product:20% co-pay OUTSIDE preferred hospitals, capped Rp50M-Rp100M/yr; 0% in-network

Read:Network-steering co-pay, already built in. See Section 8.

DEDUCTIBLE OPTION

Category typical:Optional deductibles on some plans

This product:Optional deductible (Smart plans only: Rp5M-Rp20M per treatment)

Read:Lowers contribution in exchange for first-rupiah risk.

CONTRIBUTION STRUCTURE

Category typical:Age-banded, rising yearly-renewable

This product:Yearly Renewable Term; rises with age

Read:Standard for the category; escalation is the recurring objection. See Section 7.

SHARIA-SPECIFIC DIMENSIONS

AKAD (CONTRACTS)

Tabarru' (mutual donation /

hibah for tolong-menolong) +

Wakalah bil Ujrah (manager as

participants' agent for a fee).

OJK + DPS approved; Fatwa

DSN-MUI No. 21/2001.

Read:Orthodox, defensible takaful structure. No grounds to question its authenticity.

TABARRU' FUND

Participant contributions go

into the Dana Tabarru' (mutual

fund) from which claims are

paid. Standard takaful design.

UJRAH (MANAGER FEE)

Disclosed in the contribution-

allocation table:Year 1 Ujrah ~77-81% of contribution; Year 2+ ~31-38%. Tabarru' portion ~19-23% (Y1), ~62-69% (Y2+) depending on plan. Peer Ujrah range (Syariah

health):~35-45% (Sun 37-45%, AIA 35-40%) — note these peer figures are blended, not Y1.

Read:HIGH year-1 Ujrah load. This is a real talking point — but compare like-for-like (Y1 vs Y1) before claiming Manulife is dearer; structures differ.

SURPLUS UNDERWRITING

If the Tabarru' fund runs a

surplus, Manulife returns it

TO THE DANA TABARRU' (the fund),

NOT distributed to the

individual participant.

Read:Several Syariah peers share surplus back to participants. Manulife's fund-retention approach is a legitimate point of contrast for the Legacy Income agent.

POSITIONING SUMMARY

On STRUCTURAL dimensions

(annual limit, renewal ceiling,

plan breadth, geographic scope)

this product sits in the top

decile of the category. These

are real strengths; do not

pretend otherwise.

On ECONOMIC and SHARIA-fairness

dimensions the contest is open

high year-1 Ujrah load, a 20%

out-of-network co-pay, yearly

contribution escalation, and

surplus retained in the fund

rather than shared with the

participant are all legitimate

angles for a competing carrier.

The Legacy Income play is NOT to

attack the Sharia concept (you

sell Sharia too, via AlliSya) —

it is to compete carrier-on-

carrier on network, price

discipline, and surplus-sharing

transparency.

6. Field Talking Points (EN + ID)

Customer-facing script — use the EN / ID toggle (top-right) to switch language.

These are framed for a Legacy Income agent positioning Allianz AlliSya against a prospect who has been shown — or is considering — Manulife’s product. The tone respects the Sharia concept and competes on carrier merit.

Opening — establish a fair frame

“Manulife’s Syariah plan is a serious product — I won’t pretend otherwise. What matters is which carrier serves you best on the things that actually decide a claim: the hospital network you’ll use, how the contribution behaves over the years, and how the company handles the mutual fund’s surplus. Let’s compare on those.”

“Produk Syariah Manulife itu produk yang serius — saya nggak akan bilang sebaliknya. Yang penting, perusahaan mana yang paling melayani Anda di hal-hal yang menentukan saat klaim: jaringan rumah sakit yang Anda pakai, bagaimana kontribusinya bergerak dari tahun ke tahun, dan bagaimana perusahaan mengelola surplus dana bersama. Mari kita bandingkan di situ.”

The structural value prop — compete on Sharia, don’t concede it

“You want a plan that follows Sharia principles — and you should have one. Allianz also has a fully Syariah health plan, AlliSya, with the same Tabarru’ and Wakalah bil Ujrah foundation, OJK-approved and DPS-certified. So the question isn’t ‘Sharia or not’ — both are Sharia. The question is which carrier I can place you with, support you through claims, and stand behind.”

“Anda ingin plan yang sesuai prinsip syariah — dan memang seharusnya begitu. Allianz juga punya plan kesehatan syariah penuh, AlliSya, dengan dasar Tabarru’ dan Wakalah bil Ujrah yang sama, disetujui OJK dan disertifikasi DPS. Jadi pertanyaannya bukan ‘syariah atau bukan’ — dua-duanya syariah. Pertanyaannya: perusahaan mana yang bisa saya uruskan untuk Anda, yang saya dampingi saat klaim, dan yang saya pertanggungjawabkan.”

The Surplus Underwriting / tolong-menolong pitch (Sharia-specific)

“In takaful, your contribution goes into a shared fund — the Dana Tabarru’ — so participants help each other. A fair question to ask any plan is: when that fund runs a surplus, where does it go? Some carriers return part of the surplus back to participants. With Manulife’s plan, the surplus stays inside the fund. Neither is wrong, but you should know the difference and decide which feels right to you.”

“Dalam takaful, kontribusi Anda masuk ke dana bersama — Dana Tabarru’ — supaya para peserta saling tolong-menolong. Pertanyaan yang wajar untuk ditanyakan ke plan manapun: kalau dana itu surplus, ke mana perginya? Ada perusahaan yang mengembalikan sebagian surplus ke peserta. Di plan Manulife, surplusnya tetap di dalam dana. Dua-duanya sah, tapi Anda berhak tahu bedanya dan memutuskan mana yang cocok buat Anda.”

Close — network and price discipline

“Before you decide, do two things: check whether your usual hospital is in the carrier’s preferred network — outside it, you can face a 20% co-payment — and ask for a year-one and year-five contribution figure side by side. The plan that wins on your hospital and on the multi-year cost is the plan you should hold. Let me pull those numbers for AlliSya so you’re comparing like for like.”

“Sebelum memutuskan, lakukan dua hal: cek apakah rumah sakit langganan Anda masuk jaringan preferred perusahaan — di luar itu, bisa kena co-payment 20% — dan minta angka kontribusi tahun pertama dan tahun kelima berdampingan. Plan yang menang di rumah sakit Anda dan di biaya beberapa tahun ke depan, itu yang sebaiknya Anda pegang. Saya tarikkan angka AlliSya supaya perbandingannya apel-ke-apel.”

7. Top 5 Customer Objections + Handling

Customer-facing script — use the EN / ID toggle (top-right) to switch language.

Framed for the Legacy Income agent. Full EN + ID parity. These are the objections a prospect raises in favour of the Manulife product, and how to handle them without disrespecting the Sharia premise.

1. “Is Manulife’s plan really Sharia? It feels more authentic.”

Customer “Manulife ini beneran syariah kan? Rasanya lebih asli.”

Don't say “It’s not really Sharia.” — false and disrespectful; it will destroy your credibility.

Don't say “Itu nggak beneran syariah kok.”

Do say “It is genuinely Sharia — OJK-approved and DPS-certified, exactly as it should be. But authenticity isn’t exclusive to one carrier. Allianz AlliSya runs on the identical Tabarru’ and Wakalah bil Ujrah structure, equally certified. Both are real takaful. So judge them on carrier service and fund fairness, not on who ‘feels’ more Islamic — they’re equally compliant.”

Do say “Itu memang syariah betulan — disetujui OJK dan disertifikasi DPS, persis sebagaimana mestinya. Tapi keaslian itu bukan milik satu perusahaan saja. Allianz AlliSya pakai struktur Tabarru’ dan Wakalah bil Ujrah yang sama persis, sama-sama tersertifikasi. Dua-duanya takaful asli. Jadi nilailah dari layanan perusahaan dan keadilan dananya, bukan dari mana yang ‘terasa’ lebih islami — dua-duanya sama-sama patuh.”

2. “My BSI / Islamic bank already offers something — why not just take that?”

Customer “BSI saya sudah nawarin produk, kenapa nggak ambil dari situ aja?”

Don't say “Bank products are bad.” — dismissive and untrue.

Don't say “Produk bank itu jelek.”

Do say “Bancassurance Sharia products can be convenient, but they’re usually simpler and often have lower limits and a thinner hospital network than a dedicated agency medical plan. A comprehensive plan like AlliSya or this Manulife tier gives you as-charged surgery, ICU, and a much larger annual limit. Take the bank’s offer if your need is basic; take a full medical card if you want real protection. Let me show you the difference in limits and network side by side.”

Do say “Produk bancassurance syariah memang praktis, tapi biasanya lebih sederhana, limitnya lebih kecil, dan jaringan rumah sakitnya lebih tipis dibanding plan kesehatan keagenan yang lengkap. Plan komprehensif seperti AlliSya atau tier Manulife ini memberi Anda biaya bedah sesuai tagihan, ICU, dan limit tahunan yang jauh lebih besar. Ambil tawaran bank kalau kebutuhan Anda dasar; ambil kartu kesehatan penuh kalau Anda mau proteksi sungguhan. Saya tunjukkan bedanya limit dan jaringan berdampingan.”

3. “Doesn’t insurance involve riba? Why is Syariah different?”

Customer “Asuransi kan ada ribanya? Bedanya syariah apa?”

Don't say “Don’t worry about riba.” — dismisses a sincere religious concern.

Don't say “Jangan pikirin riba lah.”

Do say “That’s the right question, and it’s exactly why takaful exists. In a Syariah plan your contribution is a donation (Tabarru’) into a shared mutual-help fund — participants help each other, not a bank charging interest. The manager earns a disclosed fee (Ujrah) for managing it, not interest. That structure is what frees it from riba and gharar concerns. AlliSya uses the same principles — so you get the Sharia comfort and a carrier I can fully support you with.”

Do say “Itu pertanyaan yang tepat, dan justru itu sebabnya takaful ada. Di plan syariah, kontribusi Anda adalah donasi (Tabarru’) ke dana tolong-menolong bersama — peserta saling membantu, bukan bank yang membebankan bunga. Pengelola mendapat fee yang transparan (Ujrah) untuk mengelolanya, bukan bunga. Struktur itulah yang membebaskannya dari riba dan gharar. AlliSya pakai prinsip yang sama — jadi Anda dapat ketenangan syariahnya sekaligus perusahaan yang bisa saya dampingi sepenuhnya.”

4. “Manulife’s limit is Rp20 billion — that’s much bigger.”

Customer “Limit Manulife sampai Rp20 miliar — itu jauh lebih besar.”

Don't say “That limit is fake / useless.” — it isn’t fake.

Don't say “Limit segitu cuma gimmick.”

Do say “The Rp20 billion figure is real, but it’s the top plan, and almost no one ever spends near it — even a serious cancer or heart treatment rarely approaches that. What you actually use in a claim is the room rate, the surgery cover, and your hospital being in-network. I’d rather match you to a plan whose contribution is sensible and whose network fits your hospital than sell you a Rp20B headline you pay for but never touch. Let’s compare the real claim mechanics, not the cover photo.”

Do say “Angka Rp20 miliar itu nyata, tapi itu plan teratas, dan hampir tidak ada yang pernah memakainya mendekati segitu — bahkan perawatan kanker atau jantung yang serius jarang sampai ke sana. Yang Anda pakai saat klaim itu tarif kamar, biaya bedah, dan rumah sakit Anda masuk jaringan. Saya lebih suka mencarikan Anda plan yang kontribusinya masuk akal dan jaringannya cocok dengan rumah sakit Anda, daripada menjual headline Rp20 miliar yang Anda bayar tapi tak pernah sentuh. Mari bandingkan mekanika klaim yang sebenarnya, bukan foto sampulnya.”

5. “Is Syariah more expensive than conventional?”

Customer “Syariah lebih mahal nggak dibanding konvensional?”

Don't say “Syariah is always cheaper.” — not true; it can cost more in year one.

Don't say “Syariah pasti lebih murah.”

Do say “Honestly, Syariah isn’t automatically cheaper — in the first year the manager fee (Ujrah) can be a large share of your contribution, on this Manulife plan as much as 77 to 81 percent in year one. So you’re choosing Syariah for the principle and the mutual-help structure, not because it’s the lowest price. If price is your only criterion, a conventional plan may quote lower. If the Sharia structure matters to you, I’ll get you there with a carrier and a contribution that make sense over several years, not just year one.”

Do say “Jujur, syariah tidak otomatis lebih murah — di tahun pertama, fee pengelola (Ujrah) bisa jadi porsi besar dari kontribusi Anda, di plan Manulife ini bahkan sampai 77 hingga 81 persen di tahun pertama. Jadi Anda memilih syariah karena prinsip dan struktur tolong-menolongnya, bukan karena paling murah. Kalau harga satu-satunya kriteria, plan konvensional bisa jadi lebih rendah. Kalau struktur syariahnya yang penting buat Anda, saya antarkan ke perusahaan dan kontribusi yang masuk akal untuk beberapa tahun ke depan, bukan cuma tahun pertama.”

8. Compliance Red Flags & Mis-Selling Warnings

These apply both to understanding the Manulife product and to writing Allianz AlliSya cleanly. Build Legacy Income training around all of them.

  1. POJK 36/2025 co-payment regime (effective January 2026). Every health product must now apply a co-payment structure. MiUltimate Healthcare Syariah applies 20% co-pay on treatment outside Manulife Preferred Hospitals (capped Rp50M/yr for Topaz–Sapphire tiers, Rp100M/yr for Diamond–Emerald tiers); 0% co-pay in-network. Any agent — Manulife or Legacy Income — who quotes “fully cashless, no out-of-pocket” without disclosing the out-of-network co-pay is mis-selling under the new regime. Always disclose the co-pay and confirm the customer’s hospital is in-network.

  2. Tabarru’ fund deficit risk. The Dana Tabarru’ is a mutual-help fund; in a takaful structure, sustained adverse claims can pressure the fund. Surplus here is returned to the fund (not the participant), which supports resilience, but the customer should understand that benefits are paid from a collective fund, not an individual account. Do not represent contributions as a personal savings balance.

  3. Wakalah bil Ujrah fee transparency. The Ujrah (manager fee) is high in year one (~77–81% of contribution per the allocation table). This is disclosed in the RIPLAY but easily glossed over verbally. Walk the customer through the year-1 vs year-2+ Ujrah split honestly — failing to disclose the front-loaded fee is a classic Syariah mis-selling complaint.

  4. Akad clarity at SPAJ stage. Syariah products require the customer to understand and agree to the specific Akad (Tabarru’, Wakalah bil Ujrah). The application (Surat Permintaan / Formulir Pendaftaran Syariah) must reflect genuine informed consent to the Akad — not a rushed signature. Confirm the customer can state, in their own words, that their contribution is a donation to a mutual fund managed by the company for a fee.

  5. 12-month pre-existing / specified-illness exclusion. A long list of conditions (all tumours/cancers, cardiovascular disease and stroke, diabetes, hypertension, hernia, kidney/bladder stones, thyroid disease and more) is excluded if it arises within 12 months of policy issuance; cataract has a 2-year wait; cancer diagnosed within 90 days of issuance is excluded; 30-day general elimination period; 12-month HIV/AIDS elimination. Cashless is unavailable for chronic and 18 specified illnesses for the first 2 years (reimbursement still applies). A clean SPAJ that hides a known condition creates a future repudiation — and a complaint. Underwrite honestly.

  6. Yearly-renewable contribution escalation. This is a Yearly Renewable Term medical card: contributions rise with age at each renewal. Selling it on a low year-1 contribution without warning the customer that it will climb materially over the years is mis-selling. Show a multi-year contribution trajectory, not just the entry figure.

  7. Geographic / plan-tier mismatch. The plan tiers carry very different geographic scopes (worldwide ex-USA at Diamond down to Indonesia-only at Jade/Sapphire) and very different room rates. Selling a low tier to a customer who expects worldwide cover, or a Diamond to a customer who never travels and cannot afford the contribution, are both mis-sells. Match the tier to the actual need and budget.


9. Quick-Reference Spec Card


BASIC

Product

MiUltimate Healthcare

Syariah

Type

Syariah health

(takaful), comprehensive

cashless / as-charged

Manager

PT Asuransi Jiwa

Manulife Syariah

Indonesia (Pengelola)

Channel

Agency

Currency

Rupiah (IDR)

Plan tiers

Diamond, Ruby, Emerald,

Topaz, Topaz Indonesia,

Jade, Jade Indonesia,

Sapphire (+ Smart

variants w/ deductible)

TERMS

Coverage

Renewable yearly (YRT)

to insured age 110

(last renewal at 109)

Entry age

Policyholder:18+

Insured:1mo - 70 yrs

Spouse:18 - 70 yrs

Child:1mo - 17 yrs (covered to age 25) Maternity rider: insured 20 - 43 yrs

Pay freq

Annual / semi-annual /

quarterly / monthly

Doc

RIPLAY/brochure 2026-04-29

(doc version Jan 2025)

BENEFITS

Annual limit

Rp20B (Diamond) down

to Rp2B (Sapphire)

Limit booster

up to Rp15B (Diamond)

for all illnesses

Basis

As-charged (sesuai

tagihan) on core

hospital items

Room

Rp3.0M/day (Diamond)

to Rp500K/day (entry)

or standard room,

whichever higher

ICU/surgery

As-charged

Cancer/dialysis

As-charged

Riders

Outpatient, dental,

maternity (optional)

No Claim Bonus

+10%/yr limit,

max +50%

No Claim Disc

10% (1yr) / 15% (2yr+)

Family disc

5%

Dana Marhamah

Rp30M (death benefit)

WAITING PERIODS

General elimination

30 days

HIV/AIDS

12 months

Specified illnesses

(cancer, cardio,

diabetes, etc.)

12 months

Cataract

2 years

Cancer (diagnosed

near issuance)

90 days

Cashless for chronic

+ 18 specified

2 yrs (reimburse

only meanwhile)

Maternity rider

1 year

EXCLUSIONS NOTABLE

Pre-existing conditions

Congenital / hereditary disease

Dental (unless accident)

Cosmetic / plastic surgery

Self-inflicted injury / suicide

Hazardous sports & activities

Sex-change procedures

Mental / psychiatric disorders

War, riot, military service

Fertility / pregnancy

(unless maternity rider)

Experimental / unproven treatment

RISIKO SENDIRI / co-payment

20% co-pay OUTSIDE Manulife

Preferred Hospitals

0% co-pay IN-NETWORK

Co-pay annual cap

Rp50M (Topaz/Jade/Sapphire)

Rp100M (Diamond/Ruby/Emerald)

Optional deductible (Smart plans)

Rp5M - Rp20M per treatment

Co-pay excludes daily cash benefit,

Dana Marhamah, traffic-accident

care, Hajj/Umrah outpatient

SHARIA STRUCTURE

Akad Tabarru'

Donation (hibah)

into the mutual-help fund for

tolong-menolong among participants

Akad Wakalah bil Ujrah

Manager

acts as participants' agent to

manage the Tabarru' fund for a

fee (Ujrah)

Ujrah (fee)

Year 1 ~77-81% of

contribution; Year 2+ ~31-38%

Tabarru' share

Year 1 ~19-23%;

Year 2+ ~62-69% (varies by plan)

Surplus Underwriting

returned to

the Dana Tabarru' (the fund) —

NOT distributed to the individual

participant

Certification

OJK-approved + DPS;

Fatwa DSN-MUI No. 21/2001

POLICY MECHANICS

Free look

14 calendar days

Grace period

45 calendar days

Claim payment

within 30 days of

approval

Reimburse filing

within 30 days

of treatment end

Cashless + reimbursement both

available

10. Action Items for Legacy Income (next 30 days)

  1. Build a one-page “AlliSya vs MiUltimate Healthcare Syariah” comparison sheet in EN + ID, focused on the three dimensions that decide a claim: hospital network, year-1-vs-year-5 contribution, and co-payment exposure. Avoid attacking the Sharia concept — compete carrier-on-carrier. This is the single highest-leverage asset for agents facing this competitor.

  2. Create a “surplus-sharing” talking-point card. Manulife returns Surplus Underwriting to the Tabarru’ fund, not to the participant. Confirm exactly how Allianz AlliSya handles surplus, then build an honest contrast point. If AlliSya shares surplus back to participants, this becomes a clean differentiator; if it also retains it, train agents to compete elsewhere rather than over-claim.

  3. Train every Sharia-conversation agent on the Ujrah-load reality. Drill the year-1 vs year-2+ fee split so agents can handle the “is Syariah cheaper?” objection truthfully and pivot the conversation to principle-and-structure, not price. Honesty here builds the trust that converts.

  4. Co-payment readiness under POJK 36/2025. Ensure every agent can explain the new co-payment regime and how AlliSya’s co-pay design compares to Manulife’s 20% out-of-network structure. Customers will hear “co-payment” from every carrier in 2026 — the agent who explains it clearly wins trust.

  5. Network-check discipline at first meeting. Before any Sharia health pitch, the agent should ask which hospital the prospect uses and confirm whether it sits in the AlliSya preferred network. Lead with the network reality; it is the most concrete, least disputable point of comparison and the fastest route to a credible recommendation.


This brief is generated by AI and may contain mistakes. Please exercise discretion. It is intended as an internal user training and positioning resource, not as a customer-facing sales document. All statements about the product are reconstructed from the official RIPLAY and brochure as downloaded 2026-04-29; the policy itself is the binding document. Compliance disclosures, competitor comparisons, and customer-fit guidance reflect analyst judgment and should be reviewed by user before being deployed in agent training materials.

Switch to Expert (top-right) for the full 10-section brief, benchmarks, compliance flags, and source documents.